Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

84 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Methotrexate Versus Mycophenolate Mofetil Prophylaxis in Allogeneic Hematopoietic Cell Transplantation for Chronic Myeloid Malignancies: A Retrospective Analysis on Behalf of the Chronic Malignancies Working Party of the EBMT.
Luft T, Gras L, Koster L, Kröger N, Schröder T, Platzbecker U, Sockel K, de Latour RP, Stelljes M, Sengeloev H, Eder M, Blau IW, Dreger P, Yakoub-Agha I, Maertens J, Salmenniemi U, Bethge W, Mielke S, Kobbe G, Pouli A, de Wreede LC, Raj K, Drozd-Sokolowska J, McLornan DP, Robin M. Luft T, et al. Among authors: sockel k. Am J Hematol. 2025 Jan;100(1):38-51. doi: 10.1002/ajh.27531. Epub 2024 Nov 28. Am J Hematol. 2025. PMID: 39605194
Methodology and clinical utility of longitudinal UBA1 tracking in VEXAS syndrome.
Gurnari C, Galossi E, Lumia E, Piciocchi A, Divona M, Casciani E, Romano F, Diral E, Tomelleri A, Caroni F, Vitale A, Bergonzi GM, Condorelli A, Battipaglia G, Morsia E, Crisà E, Triggianese P, Savi A, Cardamone C, Dragani M, Rivoli G, Pilo F, Firinu D, Plebani S, D'Agostino F, D'Ambrosio A, Sockel K, Papayannidis C, Salmoiraghi S, Pane F, Bocchia M, Cantarini L, Frigeni M, Campochiaro C, Dagna L, Greco R, Ciceri F, Spinelli O, Thiede C, Voso MT. Gurnari C, et al. Among authors: sockel k. Br J Haematol. 2024 Nov 13. doi: 10.1111/bjh.19897. Online ahead of print. Br J Haematol. 2024. PMID: 39533868
Real world outcome analysis of treosulfan-based conditioning prior to allo-HCT in patients with MDS compared to clinical trial data.
Stelljes M, Sockel K, Floeth M, Schetelig J, Bornhäuser M, Reicherts C, Lenz G, Schroeder T, Markiewicz M, Labussiere-Wallet H, Reményi P, Ciceri F, Khan I, Pichlmeier U, Li X, Stölzel F. Stelljes M, et al. Among authors: sockel k. Bone Marrow Transplant. 2025 Jan;60(1):103-106. doi: 10.1038/s41409-024-02456-3. Epub 2024 Nov 5. Bone Marrow Transplant. 2025. PMID: 39500997 No abstract available.
Comprehensive sequential genetic analysis delineating frequency, patterns, and prognostic impact of genomic dynamics in a real-world cohort of patients with lower-risk MDS.
Mazzeo P, Ganster C, Wiedenhöft J, Shirneshan K, Rittscher K, Brzuszkiewicz EB, Steinemann D, Schieck M, Müller-Thomas C, Treiber H, Braulke F, Germing U, Sockel K, Balaian E, Schanz J, Platzbecker U, Götze KS, Haase D. Mazzeo P, et al. Among authors: sockel k. Hemasphere. 2024 Sep 23;8(9):e70014. doi: 10.1002/hem3.70014. eCollection 2024 Sep. Hemasphere. 2024. PMID: 39315323 Free PMC article.
MoReLife - real-life data support the potential of momelotinib as a safe and effective treatment option for cytopenic myelofibrosis patients.
Jilg S, Schwaab J, Sockel K, Crodel CC, Brueckl V, Stegelmann F, Jentzsch M, Sasca D, Moyses M, Fuhrmann S, Gundel D, Caduc M, Teichmann LL, Heidel F, Al-Ali HK, Petrides PE. Jilg S, et al. Among authors: sockel k. Ann Hematol. 2024 Oct;103(10):4065-4077. doi: 10.1007/s00277-024-05908-4. Epub 2024 Jul 29. Ann Hematol. 2024. PMID: 39073589
Hope for motherhood: pregnancy after allogeneic hematopoietic cell transplantation (a national multicenter study).
Sockel K, Neu A, Goeckenjan M, Ditschkowski M, Hilgendorf I, Kröger N, Ayuk FA, Stoelzel F, Middeke JM, Eder M, Bethge W, Finke J, Bertz H, Kobbe G, Kaufmann M, Platzbecker U, Beverungen D, Schmid C, von Bonin M, Egger-Heidrich K, Heberling L, Trautmann-Grill K, Teipel R, Bug G, Tischer J, Fraccaroli A, Fante M, Wolff D, Luft T, Winkler J, Schäfer-Eckart K, Scheid C, Holtick U, Klein S, Blau IW, Burchert A, Wulf G, Hasenkamp J, Schwerdtfeger R, Kaun S, Junghanss C, Wortmann F, Winter S, Neidlinger H, Theuser C, Beyersmann J, Bornhaeuser M, Schmeller S, Schetelig J. Sockel K, et al. Blood. 2024 Oct 3;144(14):1532-1542. doi: 10.1182/blood.2024024342. Blood. 2024. PMID: 39007722
Immune-monitoring of myelodysplastic neoplasms: Recommendations from the i4MDS consortium.
Tentori CA, Zhao LP, Tinterri B, Strange KE, Zoldan K, Dimopoulos K, Feng X, Riva E, Lim B, Simoni Y, Murthy V, Hayes MJ, Poloni A, Padron E, Cardoso BA, Cross M, Winter S, Santaolalla A, Patel BA, Groarke EM, Wiseman DH, Jones K, Jamieson L, Manogaran C, Daver N, Gallur L, Ingram W, Ferrell PB, Sockel K, Dulphy N, Chapuis N, Kubasch AS, Olsnes AM, Kulasekararaj A, De Lavellade H, Kern W, Van Hemelrijck M, Bonnet D, Westers TM, Freeman S, Oelschlaegel U, Valcarcel D, Raddi MG, Grønbæk K, Fontenay M, Loghavi S, Santini V, Almeida AM, Irish JM, Sallman DA, Young NS, van de Loosdrecht AA, Adès L, Della Porta MG, Cargo C, Platzbecker U, Kordasti S; i4MDS consortium. Tentori CA, et al. Among authors: sockel k. Hemasphere. 2024 May 15;8(5):e64. doi: 10.1002/hem3.64. eCollection 2024 May. Hemasphere. 2024. PMID: 38756352 Free PMC article.
Does IPSS-R downstaging before transplantation improve the prognosis of patients with myelodysplastic neoplasms?
Scheid C, Eikema DJ, van Gelder M, Salmenniemi U, Maertens J, Passweg J, Blaise D, Byrne JL, Kröger N, Sockel K, Chevallier P, Bourhis JH, Cornelissen JJ, Sengeloev H, Finke J, Snowden JA, Gedde-Dahl T, Cornillon J, Schanz U, Patel A, Koster L, de Wreede LC, Hayden P, Raj K, Drozd-Sokolowska J, Gurnari C, Onida F, McLornan DP, Robin M, Yakoub-Agha I. Scheid C, et al. Among authors: sockel k. Blood. 2024 Jul 25;144(4):445-456. doi: 10.1182/blood.2023022273. Blood. 2024. PMID: 38728380
Mutations in the splicing factor SF3B1 are linked to frequent emergence of HLA-DRlow/neg monocytes in lower-risk myelodysplastic neoplasms.
Winter S, Schneider M, Oelschlaegel U, Maggioni G, Riva E, Raddi MG, Bencini S, Peruzzi B, Choy D, Antunes Dos Reis R, Güse E, Lischer C, Vera J, Timms JA, Sompairac N, Sockel K, Poloni A, Tunger A, Della Porta MG, Santini V, Schmitz M, Platzbecker U, Kordasti S. Winter S, et al. Among authors: sockel k. Leukemia. 2024 Jun;38(6):1427-1431. doi: 10.1038/s41375-024-02249-z. Epub 2024 Apr 17. Leukemia. 2024. PMID: 38632316 Free PMC article. No abstract available.
84 results